Mayo Clinic Ventures

About The Fund

Mayo Clinic Ventures is the corporate venture capital and commercialization arm of Mayo Clinic. It focuses on seed, startup, early, and later-stage investments, strategically channeling its resources into companies that operate within the medical technology, life sciences, bio-pharmaceuticals, medical devices, and diagnostic sectors primarily in the United States. With an investment range between $2,500,000 and $116,000,000, Mayo Clinic Ventures encompasses a comprehensive approach to innovation and commercialization. It is deeply involved in technology commercialization, strategic partnerships, and the transformation of healthcare, which it undertakes to primarily benefit patients. Mayo Clinic Ventures functions as part of Mayo Clinic's Department of Business Development, which serves as a bridge between medical advancements and the commercial sector, aiming to translate scientific discoveries into applications that can quickly and effectively improve patient care. The department has deployed over $300 million in investment capital for strategic collaborations and equity investments, and these efforts have returned over $1 billion to Mayo Clinic to support practice, education, and research since inception up to 2023. Mayo Clinic Ventures is also engaged in intellectual property evaluation and protection, technology funding and development, licensing execution and management, and startup company formation. Another facet of its operations is Corporate Development, which manages partnerships, spin-offs, mergers and acquisitions, and equity investing, embodying Mayo Clinic's commitment to innovation, collaboration, and the transformative impact on the future of healthcare.